Ultrasound-Guided 5% Dextrose Injection for Carpal Tunnel Syndrome - Trial NCT06349265
Access comprehensive clinical trial information for NCT06349265 through Pure Global AI's free database. This Phase 4 trial is sponsored by Kastamonu University and is currently Completed. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 33 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Carpal Tunnel Hydrodissection with %5 dextrose in water injection
Interventional
drug
Sponsor & Location
Kastamonu University
Timeline & Enrollment
Phase 4
Oct 02, 2023
Mar 02, 2024
Primary Outcome
Visual Analogue Scale(VAS)
Summary
This study was a prospective randomized double-blind clinical trial conducted at the Physical
 Medicine and Rehabilitation Clinic of a local research and training hospital in Turkey from
 October 2023 and May 2024. Patients diagnosed with CTS were classified into three groups:
 severe, mild, and moderate CTS, based on the results of electrophysiological tests. An
 ultrasound-guided 5% Dextrose in Water injection was performed. The primary outcome
 measurement was the Visual Analog Scale (VAS), while secondary measurements were the Boston
 Carpal Tunnel Syndrome Questionnaire (BCTQ) and the Dolour Neuropathic en 4 Questions (DN4)
 questionnaire. The measurements were performed before the injection and at the first week,
 first month and third month follow-up times. The distribution of data within groups was
 examined using the Shapiro-Wilk test and Q-Q plots. The study also analyzed temporal changes,
 group differences, and intergroup changes using repeated measures ANOVA models.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06349265
Non-Device Trial